Latest news

Skin Cancer

10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma

Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.

Oncology Pharmacy Team Apr 23, 2025

Head & Neck Cancer

Durvalumab vs Cetuximab: No Advantage in Head and Neck Cancer Trial

Study finds durvalumab with radiotherapy no better than cetuximab for cisplatin-ineligible head and neck cancer

Oncology Pharmacy Team Apr 21, 2025

Colorectal Cancer

Timing is Everything: Early Chemotherapy Boosts Colorectal Cancer Survival

Study finds starting chemotherapy within 6 weeks after colorectal cancer surgery improves survival rates.

Oncology Pharmacy Team Apr 18, 2025

Disease States